Viktor L. Popkov

Viktor L. Popkov

Auto-generated profile, based on publicly available information

Viktor L. Popkov

Kuban State Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Stomatology for all / International Dental Review
Verified
Journal Article
Closed access
VLV.K. Leontyev
V.K. Leontyev
KTK.V. Tseluyko
K.V. Tseluyko
AZA.V. Zadorozhny
A.V. Zadorozhny
VPV.L Popkov
V.L Popkov
PGP.A. Galenko-Yarochevsky
P.A. Galenko-Yarochevsky
A representative and randomized study of the effect of a combination of nanosilver and a new injection form of Rexod® on the periodontal tissues state of animals (rats) in an experimental model of inflammatory pathology of periodontal tissues (experimental periodontitis) was carried out. It was shown that the improvement of the dental status of periodontal tissues against the background of the course application of a combination of nanosilver (topically) and a new injection form of Rexod® was accompanied by a decrease in the amount of gingival fluid of the sulcular gingival sulcus, an improvement in the clinical condition of the marginal periodontal mucosa (hyperemia was leveled, swelling decreased, the bleeding indexPBI Muhllemann-Cowell decreased, test Schiller-Pisarev results normalised). The decrease in the number of gum fluids is due to the decrease in antibacterial activity of pathogenic microflora and their products of their life-based hemodynamics of the peripheral microvascular network (exchange capabulars) of the periodontal, a decrease in perfusion pressure in them, reduced (narrowing) of their lumen, reduce their permeability and restoration of oxidation-reduction processes.

30 January 2024 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
OSOlga V. Shelemekh
Olga V. Shelemekh
VPViktor L. Popkov
Viktor L. Popkov
AZAndrey V. Zadorozhniy
Andrey V. Zadorozhniy
INIrina B. Nektarevskaya
Irina B. Nektarevskaya
NKNikolay E. Korovaykin
Nikolay E. Korovaykin
Introduction: Although nonsteroidal anti-inflammatory drugs (NSAIDs) have a clear therapeutic benefit, they can also have serious side effects. The most serious of these is the ulcerogenic effect, which can result in a decline in the quality of life or even death. This calls for the search for and creation of novel compounds with potent anti-inflammatory properties that do not have adverse effects on the digestive system. The aim of the study was to investigate the anti-inflammatory, analgesic, ulcerogenic and anti-ulcerogenic activities of N-isopropenylimidazole zinc complex derivative. Materials and Methods: Experiments in rats and mice were used to determine the median lethal dose LD50 for N-isopropenylimidazole zinc complex derivative (laboratory name Pilim-1). Experimental models of acute exudative inflammation and chronic proliferative inflammation were used. In the first case, the inflammation was induced by sub-plantar injection of carrageenan and a complete Freund’s adjuvant into the hind paw of rats. In the second case, the inflammation was induced by the implantation of a sterile cotton pellet (“cotton pellet–induced granuloma”) under the skin of rats. Acute and tonic pain, visceral, and somatic deep pain were simulated using the formalin test in rats and the acetic acid-induced writhing test in mice, respectively. The ulcerogenic and anti-ulcerogenic effects of Pilim-1 were studied in rat experiments. Pilim-1 and the reference drugs diclofenac, indomethacin and famotidine were administered intragastrically. Results and Discussion: Pilim-1 showed marked anti-inflammatory and analgesic effects, demonstrated less toxicity than diclofenac and indomethacin, while its activity is comparable to diclofenac and superior to indomethacin. Its therapeutic index is higher than that of indomethacin and diclofenac and, in contrast, it essentially has no ulcerogenic effect and exhibits stronger anti-ulcerogenic activity than famotidine. It appears that the anti-inflammatory, analgesic, and gastroprotective properties of Pilim-1 are largely due to its antioxidant and antihypoxic properties, its inhibitory effects on cyclooxygenase and 5-lipoxygenase, and the presence of imidazole and zinc in its structure, both of which have a wide range of biological activity. Conclusion: Pilim-1 can be recommended for further preclinical studies due to its relatively low (practically absent) ulcerative activity, strong anti-inflammatory, analgesic, and anti-ulcerative effects, greater therapeutic index, and less acute toxicity in comparison with diclofenac and indomethacin.

4 October 2023 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
ASAleksandr А. Slavinskiy
Aleksandr А. Slavinskiy
STSergey S. Todorov
Sergey S. Todorov
VPViktor L. Popkov
Viktor L. Popkov
OSOlga V. Shelemekh
Olga V. Shelemekh
AVAleksandr А. Verevkin
Aleksandr А. Verevkin
Introduction: Combined inflammatory and destructive processes affecting the dental pulp and tissues of the periodontal complex are among the most problem diseases of the dental system. Current therapy with use of available pharmacological agents does not always allow achieving the expected positive result. In addition, often the lack of information about morphological processes in the tissues of the dental system, in particular the gums, with endodontic-periodontal lesion (EPL) limits the ability of dentists to carry out targeted pharmacotherapy with both traditional and, in particular, new medications. The aim of the study was to evaluate the morphological characteristics of gum tissues in a therapeutic context of N-isopropenylimidazole zinc complex derivative in experimental endodontic-periodontal lesion in rats.  Materials and Methods: A simulation of EPL in rats was performed in two ways: simultaneous induction of acute periodontitis and parodontitis by pulp extraction and natural infection of the pulp cavity, as well as by ligation of the necks of lower incisors. The research protocols included 5 groups of animals: 1st – intact group (control-1); 2nd – animals with simulated EPL (control-2); 3rd – animals with simulated EPL and treated with Metrogyl Denta® gel (M-D); 4th – animals with simulated EPL and treated with N–isopropenylimidazole zinc complex derivative gel under the laboratory code Pilim-1; and 5th – animals with simulated EPL and treated with the combination of M-D + Pilim-1. The gum of the lower incisors was taken for morphological studies. Slides were stained with hematoxylin and eosin. Computer morphometry was performed using the ImageJ software. Results and Discussion: The substances M-D, Pilim-1 and, especially, the combination of M-D+Pilim-1 (against the background of chlorhexidine bigluconate used as oral rinse) for 14 days in rats with simulated EPL cause a significant improvement of the morphological structure of the gum with minimal residual dystrophy and sclerosis. The combination M-D + Pilim-1 led to a 1.3-time increase in epithelial thickness, and a 1.5-time decrease in acanthosis depth in comparison with M-D, while the number of capillaries and their diameter had no significant differences. Compared with Pilim-1, the epithelial thickness increased 1.5 times, and the acanthosis depth and the number of capillaries decreased 1.6 and 1.4 times, respectively, whereas the diameter of the capillaries did not change significantly. The pronounced protective effect of the combination M-D + Pilim-1 on the morphological structure of the gingival mucosa of rats with simulated EPL may be associated with antimicrobial, anti-inflammatory, regenerating, angioprotective and antioxidant properties of both M-D and Pilim-1 separately, and, possibly to a greater extent, of the combination M-D + Pilim-1. Conclusion: The substances M-D, Pilim-1 and, especially, the combination M-D + Pilim-1 (against the background of chlorhexidine bigluconate used as oral rinse) for 14 days in rats with simulated EPL have a protective effect on the epithelial structure and the connective tissue of the proper mucous plate, manifested in active normalization of pathological changes and significant restoration of their organotypic structure.

24 June 2022 in Stomatology for all / International Dental Review
Verified
Journal Article
Closed access
VPV.L. Popkov
V.L. Popkov
МZМ.A. Zadorozhny
М.A. Zadorozhny
AHA.V. Heigetyan
A.V. Heigetyan
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
The study explored the possibility of combining the multitargent means of gel Soderm®-Forte and the metabolic energy corrector Cytoflavin in conditions of inflammatory pathology of periodontal tissues on a model of induced experimental periodontitis in rats. It is shown that the conduct of complex pharmacotherapy with drugs with antimicrobial, anti-inflammatory, energy-correcting and antioxidant orientation helps to reduce inflammatory phenomena in periodontal tissues, normalize osmotic exudation of the gingival fluid of the sulcular region and restore the index assessment of the tissues of the periodontal complex. The paper substantiates and shows the significance of the use of these drugs that can have a prolonged therapeutic effect on the peripheral microvascular network in the region of the gingival groove, reducing the exudative component in the postcapillary venules and arterioles by lowering perfusion pressure and reducing their permeability and improving protective effects under hypoxia.

27 March 2019 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
VPVictor L. Popkov
Victor L. Popkov
KBKarine A. Bedrosova
Karine A. Bedrosova
LFLeonid A. Faustov
Leonid A. Faustov
GSGalina Sukoyan
Galina Sukoyan
VDValeriya S. Dobrodomova
Valeriya S. Dobrodomova
Introduction: A promising compound for the treatment of inflammatory periodontal diseases is benzofuracaine (BFC) .BFC has pronounced anti-inflammatory, analgesic, reparative, hypoglycemic and other effects. Objective: To assess the influence of benzofuracaine on experimental periodontitis and to study its antidiabetic activity and molecular mech-anisms of action Materials and methods: The work was performed on 232 white nonlinear rats of both sexes and 55 male mice. To assess the effect of BFС on experimental periodontitis, the amount of gingival fluid (AGF) was determined, an in-depth morphofunctional study of periodontal tissues was conducted, as well as the study of the biochemical composition of the gingiva and blood. Antidiabetic properties were studied using the glucose tolerance test (GTT), as well as the as-sessment of endothelium-dependent vasodilation and transmembrane K+-currents on an isolated aortic segment of ratswith streptozotocin-induced diabetes mellitus (DM). Results and discussion: In experimental periodontitis, BFC improves the morphological picture and decreases AGF, in-creases the level of blood microcirculation in the attached gingiva, has a normalizing effect on the prekallikrein-kallikrein system, reduces the synthesis of bradykinin, proinflammatory cytokines and PGE2, increases the level of VEGF, reduces the level of endothelin-1, increases the ATP content and NADH-ubiquinone-reductase activity, exhibits antioxidant properties,reduces the content of nitrosothiols and NO metabolites (NO2/NO3), increases the level of transferrin; when conducting a glucose tolerance test in mice, it reduces the level of glucose in the blood, but in this respect is inferior to glibenclamide, has a hypoglycemic effect in the early stages of diabetes (30 days), tends to restore endothelium-dependent dilatation of smooth muscle cells (SMC) of the aorta and does not affect the functioning of the K+-channels of the aortic SMC. Conclusion: BFС is an effective drug for the treatment of periodontitis and can be recommended for further preclinical and clinical studies.

30 March 2022 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
PGPavel A. Galenko-Yaroshevsky
Pavel A. Galenko-Yaroshevsky
TVTseluiko Kristina V.
Tseluiko Kristina V.
VLValeriy K. Leontev
Valeriy K. Leontev
MZMark A. Zadorozhniy
Mark A. Zadorozhniy
VPViktor L. Popkov
Viktor L. Popkov
SMSonya V. Meladze
Sonya V. Meladze
Introduction: Insufficient effectiveness of traditional drug therapy in a treatment of patients with chronic generalized periodontitis, as well as high social significance of this problem, determines the need to search for new drugs and their compositions aimed at solving it. Aim of the study: To increase the efficacy of complex treatment of periodontitis with the administration of Soder­m®-Forte gel and a new injectable form of Rexod®. Materials and methods: Experiments were performed in 50 male Wistar rats. Experimental periodontitis (EP) was simulated by ligation of the necks of lower incisors. We studied the animals with intact periodontium, untreated EP, and when traditional drug therapy (TDT), as well as the combinations of TDT with Soderm®-Forte gel and additionally with the new injectable dosage form (NIF) of Rexod® were administered. The general condition, behavior, nutrition and body weight of the animals were evaluated. The Schiller-Pisarev test and the Muhlemann-Cowell bleeding index were used, and the amount of crevicular fluid (CF) was measured. The contamination of the marginal gum with microorganisms was determined. Results and discussion: The TDT in EP has a moderate therapeutic effect, which does not lead to a sufficiently high pharmacotherapeutic effect, whereas the combinations of TDT with Soderm®-Forte and, to a greater extent, TDT with Soderm®-Forte and NIF of Rexod® have high therapeutic efficacy, which is statistically confirmed by a sharp decrease in the amount of CF, the Schiller-Pisarev test and the Muhlemann-Cowell bleeding index, as well as absolute suppres­sion of pathogenic microorganisms. Conclusion: The combinations of TDT with Soderm®-Forte gel and NIF of Rexod® in EP in rats can significant­ly increase the effectiveness of the treatment. The data obtained indicate the expediency of the administration of Soderm®-Forte gel, as well as its combination with NIF of Rexod® in dental practice in the complex therapy of patients with periodontitis.